Cravihenz 40mg Tablet
Marketer
Biokindle Lifesciences Pvt Ltd
Salt Composition
Megestrol (40mg)
Overview Cravihenz 40mg Tablet
Palbociclib 40mg tablets are indicated for the management of hormone receptor-positive breast cancer and endometrial cancer. This medication targets cancers dependent on hormonal activity. Additionally, it may be prescribed to address anorexia and cachexia in individuals with advanced cancers or HIV. Dosage and duration of Palbociclib 40mg therapy should be determined and monitored by your physician. Administration with or without food is acceptable, though consistent timing is recommended. Continue treatment as directed by your healthcare provider. Frequently reported adverse effects include increased body weight, enhanced appetite, dyspnea, vasomotor flushes, hypertension, and bowel irregularity. Many of these effects are transient, subsiding once the body acclimates to the treatment. Report any persistent or bothersome side effects to your doctor; management strategies may be available. Complete disclosure of all other medications is crucial, as interactions may compromise efficacy or alter the drug's mechanism. This medication is contraindicated in pregnant and lactating individuals. Your physician may order periodic blood tests to assess hormone levels and glycemia during treatment.
Primary Ingredients of Cravihenz 40mg Tablet
No text provided to rephrase.
Uses of Cravihenz 40mg Tablet
Cancers of the breast and uterus
Major Benefits of Cravihenz 40mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cravihenz 40mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Cravihenz 40mg Tablet:
- Increased appetite
- Weight gain
- Hot flashes
- High blood pressure
- Constipation
How to use Cravihenz 40mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 40mg Cravihenz tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Cravihenz 40mg Tablet works:
Ciraparanib 40mg tablets contain a progestin, a type of female hormone. This medication modifies hormone levels in women with breast or uterine cancer, thereby impacting cancer cell proliferation. A side effect is increased appetite leading to weight gain.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cravihenz 40mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Use of Cravihenz 40mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; animal and human studies reveal substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of 40mg Cravihenz tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Cravihenz 40mg tablets.
KidneyCAUTION
For individuals with severe kidney impairment, the administration of 40mg Cravihenz tablets requires careful monitoring. A modified dosage of Cravihenz 40mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cravihenz 40mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cravihenz 40mg Tablet :
NA
Facts to Know About Cravihenz 40mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Synthetic Progestins |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
3,018 People bought this recently